The health startup Qantev has secured a 30 million euro investment. The France-based company raised this amount in its Series B funding round, which included participation from Elaia Ventures, Omnes Ventures, and Raise Ventures

Qantev plans to use the new investment to develop products, expand its team, grow its market presence, strengthen customer relationships, and improve its technological infrastructure.

It is worth noting that the company received its first investment of 1.7 million dollars in 2020, followed by a 10 million euro Series A funding round two years later.

Founded in 2019 by Hadrien De March and Tarik Dadi, Qantev addresses the rising prevalence of chronic diseases and the aging population, which have led to a significant increase in health insurance claims. This situation known to challenge insurance companies as they struggle to manage the growing demand. Qantev helps these companies respond to increased customer requests by automating health insurance processes.

Qantev offers AI-based solutions that expedite the evaluation process for insurance claims. Evaluating claims through traditional methods can be time-consuming and resource-intensive. Qantev’s software allows for much faster processing of claims, enabling insurance companies to reduce costs while simultaneously improving customer satisfaction.

Moreover, it’s known that health insurance is more complex and variable compared to other types of insurance. Therefore, a one-size-fits-all solution may not suffice. Qantev utilizes customized AI models in the health insurance sector to evaluate each claim more effectively. 

On one hand, the sustainability of healthcare services has become increasingly important in the modern world. Qantev aims to enhance the sustainability of the health insurance sector through efficient processes and low costs. The company’s goal is to enable more people to access quality healthcare services and improve the overall efficiency of the healthcare system.


Source